DEF: Eagle Capital Growth Fund Announces 2025 Annual Meeting of Shareholders

Sentiment:

Proxy Statement


Eagle Capital Growth Fund, Inc. will hold its 2025 Annual Meeting of Shareholders on April 17, 2025, to elect directors and ratify the selection of independent accountants.

Summary

  • Eagle Capital Growth Fund, Inc. is holding its 2025 Annual Meeting of Shareholders on April 17, 2025, at the Milwaukee Bar Association.
  • Shareholders will vote to elect three directors to new 3-year terms.
  • They will also ratify the selection of Cohen & Company, Ltd as the independent registered public accountants for the year ending December 31, 2025.
  • The record date for determining shareholders eligible to vote is February 21, 2025.
  • As of the record date, there were 3,967,836 shares of common stock outstanding.
  • One-third of the outstanding shares constitutes a quorum for the meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions. The sentiment is slightly positive due to the routine nature of the announcements and the absence of any significant negative disclosures.

Positives

  • The Fund has an Audit Committee comprised of independent members.
  • The Board believes that the separation of the Chairman and Chief Executive Officer roles provides constructive checks and balances for shareholders.
  • All directors attended at least 75% of the meetings of the Board and committees of the Board on which he or she served during 2024.

Negatives

  • One filing related to Section 16(a) beneficial ownership reporting was made late during the year ended December 31, 2024.

Risks

  • Investment funds generally face a number of risks, including investment risk, compliance risk, and valuation risk.
  • A broker non-vote may occur if your broker fails to vote your shares for any reason.

Future Outlook

The Advisory Agreement between the Fund and the Advisor has been mutually extended through February 2026.

Management Comments

  • The Fund believes that Warren Buffett and Charles Munger of Berkshire Hathaway, Inc. have succinctly identified the key qualifications for corporate directors and nominees for director: 1. High integrity; 2. Business savvy; 3. A shareholder orientation; and 4. A genuine interest in the company.
  • We believe that all of our nominees and continuing directors satisfy these requirements.

Industry Context

This is a standard proxy statement for a registered investment company, outlining the proposals to be voted on at the annual meeting, providing information about the directors and nominees, and disclosing fees paid to the independent accountants.

Comparison to Industry Standards

  • The director qualifications outlined by the Fund align with industry best practices, emphasizing integrity, business acumen, and shareholder focus, similar to those sought by companies like Berkshire Hathaway.
  • The fee structure for directors and audit services appears to be within the typical range for small to mid-sized investment funds, based on comparisons with similar funds' disclosures.
  • The Fund's approach to risk management, focusing on minimizing risks through independent custodians and investments in marketable securities, is a common practice among regulated investment companies.

Stakeholder Impact

  • Shareholders are asked to vote on the election of directors and the ratification of the independent accountants, which directly impacts the governance and oversight of the Fund.
  • The selection of qualified directors and auditors is intended to benefit shareholders by ensuring proper management and financial oversight of the Fund.

Next Steps

  • Shareholders should review the proxy statement and vote on the proposals.
  • The Fund will hold its Annual Meeting on April 17, 2025.
  • The Board will consider shareholder proposals received by November 14, 2025, for inclusion in the 2026 proxy statement.

Key Dates

DateDescription
February 21, 2025Record Date for determining shareholders entitled to vote at the Meeting.
March 13, 2025Approximate mailing date of the Proxy Statement.
April 17, 2025Date of the 2025 Annual Meeting of Shareholders.
November 14, 2025Deadline for shareholder proposals for the 2026 annual meeting to be received by the Fund.
December 31, 2025Calendar year end for which Cohen & Company, Ltd will examine the Funds financial statements.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.